# EDGAR Filing Document

**Accession Number:** 0001875415
**File Stem:** 0001562180-23-000772
**Filing Date:** 2023-2
**Character Count:** 8025
**Document Hash:** 9eab94adb8714ee0733a9d5e2f6477a1
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001562180-23-000772.hdr.sgml**: 20230201

**ACCESSION NUMBER**: 0001562180-23-000772

**CONFORMED SUBMISSION TYPE**: 3

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20230130

**FILED AS OF DATE**: 20230201

**DATE AS OF CHANGE**: 20230201

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Fehring Nicolas A.
- **CENTRAL INDEX KEY:** 0001875415

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-02360
- **FILM NUMBER:** 23576993

**MAIL ADDRESS:**
- **STREET 1:** ONE NEW ORCHARD ROAD
- **CITY:** ARMONK
- **STATE:** NY
- **ZIP:** 10504
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** INTERNATIONAL BUSINESS MACHINES CORP
- **CENTRAL INDEX KEY:** 0000051143
- **STANDARD INDUSTRIAL CLASSIFICATION:** COMPUTER & OFFICE EQUIPMENT [3570]
- **IRS NUMBER:** 130871985
- **STATE OF INCORPORATION:** NY
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 1 NEW ORCHARD ROAD
- **CITY:** ARMONK
- **STATE:** NY
- **ZIP:** 10504
- **BUSINESS PHONE:** 9144991900

**MAIL ADDRESS:**
- **STREET 1:** 1 NEW ORCHARD RD
- **CITY:** ARMONK
- **STATE:** NY
- **ZIP:** 10504

## Ex-24

```

International Business Machines
New Orchard Road
Armonk, NY 10504

January 30, 2023

Securities and Exchange Commission
100 F Street, NE
Washington, DC 20549

I hereby authorize each of the following individuals,
whose signatures appear below, as well as each of the
International Business Machines Corporation (IBM) employees
holding the titles of Secretary; Assistant Secretary;
Vice President, Compensation and Benefits; Vice
President, Executive Compensation; and Manager, Executive
Compensation Operations and Officer Services; and any
employee of IBM designated in writing by the Secretary of
IBM, to sign and file on my behalf as an Executive Officer
of IBM any Securities and Exchange Commission forms or
documentsin connection with any transactions by me in IBM
securities,including without limitation Form 3, Form 4,
and Form 5 under the Securities Exchange Act of 1934 and
Form 144 under the Securities Act of 1933. The specimen
signatures provided below may be signed on separate
documents, and such documents taken together shall
constitute a single document.

J. Daly		_____/s/ J. Daly_____________________
P. E. Dunkle, Jr.	______/s/ P. E. Dunkle, Jr.__________
D. Glowienka	______/s/ D. Glowienka________________
R. Hayes	___________/s/ R. Hayes_____________________
L. Mallardi	____________/s/ L. Mallardi_________________
J. Mancillas	______/s/ J. Mancillas________________
J. Pomazal	____________/s/ J. Pomazal___________________
F. Sedlarcik	______/s/ F. Sedlarcik_________________
L. Sousa	____________/s/ L. Sousa____________________

This authorization shall remain in effect for as long as
I remain an executive officer of IBM.

              			Very truly yours,

              			/s/ Nicolas Fehring
				Nicolas Fehring

```

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 3

### INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Fehring Nicolas A.<br><sub>(Last) (First) (Middle)</sub><br>IBM CORPORATION<br>ONE NEW ORCHARD ROAD<br><sub>(Street)</sub><br>ARMONK, NY 10504<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>INTERNATIONAL BUSINESS MACHINES CORP [ IBM ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2023-01-30 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director   [ ] 10% Owner<br>[X] Officer (give title below)   [ ] Other (specify below)<br>_VP, Controller_ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities Beneficially Owned

---

|  |  |  |  |
| --- | --- | --- | --- |
| 1. Title of Security | 2. Amount of Securities Beneficially Owned | 3. Ownership Form | 4. Nature of Indirect Beneficial Ownership |
| Common Stock | 4061.434 | D |  |

---

## Table II - Derivative Securities Beneficially Owned

---

|  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Underlying Securities | 3. Title and Amount of Underlying Securities | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| Emp. Stock Option (right to buy) | 2023-02-21<sup>(1)</sup> | 2032-02-20<sup>(1)</sup> | Common Stock | 7359.00 | $124.51 | D |  |
| Rst. Stock Unit | <sup>(2)</sup> | <sup>(2)</sup> | Common Stock | 2848.00 | $0.00 | D |  |
| Rst. Stock Unit | <sup>(3)</sup> | <sup>(3)</sup> | Common Stock | 386.00 | $0.00 | D |  |
| Rst. Stock Unit | <sup>(4)</sup> | <sup>(4)</sup> | Common Stock | 1051.00 | $0.00 | D |  |
| Rst. Stock Unit | <sup>(5)</sup> | <sup>(5)</sup> | Common Stock | 1545.00 | $0.00 | D |  |
| Rst. Stock Unit | <sup>(6)</sup> | <sup>(6)</sup> | Common Stock | 5484.00 | $0.00 | D |  |
| Rst. Stock Unit | <sup>(7)</sup> | <sup>(7)</sup> | Common Stock | 1578.00 | $0.00 | D |  |

---

### Footnotes:

(1) These derivative securities vest in four equal annual installments, the first vesting being on the date exercisable shown.  All expire on the expiration date shown above.

(2) Upon lapse of the restrictions, these units are payable in cash or the company's common stock. The restrictions lapse for 2,848 of these units on June 3, 2023.

(3) Upon lapse of the restrictions, these units are payable in cash or the company's common stock. The restrictions lapse for 386 of these units on June 7, 2023.

(4) Upon lapse of the restrictions, these units are payable in cash or the company's common stock. The restrictions lapse for 524 of these units on June 8, 2023 and for 527 of these units on June 8, 2024.

(5) Upon lapse of the restrictions, these units are payable in cash or the company's common stock. The restrictions lapse for 514 of these units on June 8, 2023, for 514 of these units on June 8, 2024, and for 517 of these units on June 8, 2025.

(6) Upon lapse of the restrictions, these units are payable in cash or the company's common stock. The restrictions lapse for 2,742 of these units on September 1, 2024, and for 2,742 of these units on September 1, 2025.

(7) Upon lapse of the restrictions, these units are payable in cash or the company's common stock. The restrictions lapse for 394 of these units on February 21, 2023, for 394 of these units on February 21, 2024, for 394 of these units on February 21, 2025, and for 396 of these units on February 21, 2026.

**Signature:** D. Glowienka on behalf of N. A. Fehring  
**Date:** 2023-02-01

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**